trending Market Intelligence /marketintelligence/en/news-insights/trending/17q4rr9Ho5WIm5NFRHkHIA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Repros Therapeutics names president, CEO

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Repros Therapeutics names president, CEO

Repros Therapeutics Inc. appointed Larry Dillaha as the company's permanent president and CEO.

Dillaha, who previously held chief medical officer roles at Insys Therapeutics Inc. and Sciele Pharma Inc., will also fill a vacancy on the company's board.

Dillaha was performing the duties on an interim basis following the resignation of Joseph Podolski.